FDA — authorised 15 January 1975
- Application: ANDA083029
- Marketing authorisation holder: WATSON LABS
- Local brand name: PROPANTHELINE BROMIDE
- Indication: TABLET — ORAL
- Status: approved
FDA authorised PROPANTHELINE BROMIDE on 15 January 1975
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 15 January 1975; FDA authorised it on 4 August 1976; FDA authorised it on 18 May 1983.
WATSON LABS holds the US marketing authorisation.